Cytokinetics, Incorporated
Public
CYTK
SectorHealthcare
CountryUnited States
Market cap8.09B
Cytokinetics, Incorporated,A late-stage biopharmaceutical company focused on discovering and developing muscle activators for treating debilitating cardiovascular and neuromuscular diseases.
